Patents Assigned to RVL PHARMACEUTICALS, INC.
  • COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS
    Publication number: 20240033250
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Application
    Filed: June 8, 2023
    Publication date: February 1, 2024
    Applicant: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Compositions and methods for treating ocular disorders
    Patent number: 11701343
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: May 9, 2022
    Date of Patent: July 18, 2023
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Oxymetazoline compositions
    Patent number: 11541036
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: April 25, 2022
    Date of Patent: January 3, 2023
    Assignee: RVL PHARMACEUTICALS, INC.
    Inventors: Tina Devries, David Jacobs
  • Compositions and methods for treating ocular disorders
    Patent number: 11324722
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: May 10, 2022
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Oxymetazoline compositions
    Patent number: 11311515
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: August 30, 2021
    Date of Patent: April 26, 2022
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina Devries, David Jacobs
  • Compositions and methods for treating ocular disorders
    Patent number: 11219615
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: January 11, 2022
    Assignee: RVL PHARMACEUTICALS, INC.
    Inventors: Tina deVries, David Jacobs
  • Oxymetazoline compositions
    Patent number: 11103482
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: January 21, 2021
    Date of Patent: August 31, 2021
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Compositions and methods for treating ocular disorders
    Patent number: 10940138
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: October 5, 2020
    Date of Patent: March 9, 2021
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Oxymetazoline compositions
    Patent number: 10898573
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: October 7, 2020
    Date of Patent: January 26, 2021
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Oxymetazoline compositions
    Patent number: 10814001
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of stabilizing oxymetazoline compositions for long term storage.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: October 27, 2020
    Assignee: RVL Pharmaceuticals, Inc.
    Inventors: Tina deVries, David Jacobs
  • Compositions and methods for treating ocular disorders
    Patent number: 10799481
    Abstract: The present disclosure is directed to compositions comprising oxymetazoline and methods of treating various eye disorders related to drooping eyelids, such as ptosis, in a subject comprising administering to the subject compositions comprising oxymetazoline.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: October 13, 2020
    Assignee: RVL PHARMACEUTICALS, INC.
    Inventors: Tina deVries, David Jacobs